Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes
Dear Editor, we would like to congratulate Dr. Perkovic and colleagues demonstrating that semaglutide reduced by 24% the risk of kidney outcomes and death from cardiovascular causes in persons with type 2 diabetes (T2D) and chronic kidney disease (CKD)1. In SUSTAIN 6, semaglutide showed renal benefi...
- Autores:
-
Rico-Fontalvo, Jorge
Daza-Arnedo, Rodrigo
Rodríguez-Yánez, Tomas
Soler, María J.
- Tipo de recurso:
- Fecha de publicación:
- 2024
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/16064
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/16064
https://dx.doi.org/10.24875/NEFRO.24000031
https://www.nefrologialatinoamericana.com/files/es/nefro_24_21_3_096-097.pdf
- Palabra clave:
- Type 2 diabetes
Chronic kidney disease
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivs 3.0 United States